In the news

Second annual PICR Recognition Awards celebrate outstanding contributions to cancer research

Faculty members, trainees and staff from the Purdue Institute for Cancer Research (PICR) gathered on April 10 to recognize exceptional contributions to cancer research within the institute. The ceremony honored individuals whose efforts are helping to advance science, collaboration and community across PICR.

February 5, 2025

One Health: A ‘digital twin’ model for predicting cancer outcomes

A new project at Purdue University that combines many types of available data in a "digital twin" model of bladder cancer may prove powerful enough to predict patient outcomes, starting with the probability of metastasis.

January 21, 2025

Research led by Andrisani sheds new light on liver cancer treatment

A team of researchers led by PICR member Ourania Andrisani identified three key pathways driving the resistance of liver cancer cells to sorafenib. The discovery marks a significant milestone, paving the way for innovative treatment strategies that target all three pathways simultaneously.

December 10, 2024

Ghosh one of two Purdue faculty named National Academy of Inventors 2024 fellows

Two Purdue University faculty members, including Purdue Institute for Cancer Research member Arun Ghosh, have been named fellows of the National Academy of Inventors. The 2024 fellow class includes representatives from 170 research universities, government agencies, and nonprofit research institutions worldwide.

November 15, 2024

Cancer researchers among those honored with Seed for Success Acorn Awards

Purdue recently honored 275 researchers with the university's prestigious Seed for Success Acorn Awards. The awards recognize Purdue principal investigators and co-investigators who obtain external research funding of $1 million or more for a single proposal.

October 29, 2024

WGHI-supported research could lead to blood tests for early breast cancer diagnoses

Using a highly promising approach to speed breast cancer diagnostics, researcher W. Andy Tao of the Purdue Institute for Cancer Research is studying how specific blood particles could be used to catch BRCA-related breast cancer before any tumor growth.

August 27, 2024

Tool developed by PICR member reveals untapped efficacy of cancer drug, leveling up cancer fight

Research from Majid Kazemian in collaboration with the National Institutes of Health (NIH) reveals that a cancer drug dismissed by traditional testing methods may be effective in treating bladder cancer, thanks to a new computational tool called the Pathway Ensemble Tool (PET).

Cancer researchers awarded funds from Purdue Innovates to strengthen market readiness of their work

Andrea Kasinski, Yoon Yeo and Jesse Chi Zhang have received support from the Trask Innovation Fund to further develop disease-fighting innovations for commercial use.

Sintim team develops compound to treat drug-resistant acute myeloid leukemia

Purdue researchers have developed a patent-pending compound designed to treat drug-resistant acute myeloid leukemia. PICR member Herman Sintim leads the team.

Team is using mass spectrometry to help surgeons quickly identify tumor tissue during brain surgery

PICR member R. Graham Cooks is working with a team of researchers from Purdue and Mayo Clinic to help surgeons rapidly identify mutations and improve tumor tissue removal during brain cancer surgery.